Injective, the popular Cosmos-based blockchain for decentralized finance, continued retreating amid concerns about its ecosystem. Injective (INJ) token retreated to $16.90 on Sep. 3, its lowest point ...

In 2030, our crypto analyst team and Machine Learning experts envision a varied outlook for the Injective token. Projections indicate highs near $152.37, potential lows around $47.43, with an average ...

Injective is a popular project among many crypto investors with many influencers calling for the price of $100 on this token, in this bull run. However, this token is yet to return the faith invested ...

Injective Protocol, a layer-1 blockchain focused on decentralized finance, is launching onchain pre-IPO perpetual markets, giving global investors access to trade synthetic versions of major private ...

Injective Exchange traders only pay regular market maker and taker fees using INJ coins, rather than network gas fees for each transaction. INJ coins also act as the platform’s governance token and ...

Native EVM implementation achieves 800 TPS and handles 1M lightweight transactions without relying on external bridges or third-party solutions. Integration supports advanced DeFAI capabilities and on ...

Injective, has released the testnet of its inEVM Layer 2 rollup solution in partnership with Caldera. This allows Ethereum applications to run natively on the network. Today’s date marks the testnet ...

Injective is integrating a native Ethereum Virtual Machine into its Layer 1 blockchain. This new development enables Ethereum-compatible decentralized applications on Injective. The team is starting ...

The Injective blockchain team plans to stake an additional 50 million INJ, raising the total staked to over 47.7% amid increasing TVL. The total value invested on Injective's decentralized finance ...

Injective targets $33.34 and $50 after a bullish flag breakout, signaling strong momentum. Market sentiment remains bullish, with rising RSI, MA cross, and increasing Open Interest. Injective [INJ] ...